The Advisory Board Co. (NASDAQ:ABCO) insider Cormac F. Miller sold 750 shares of The Advisory Board stock in a transaction that occurred on Wednesday, October 12th. The stock was sold at an average price of $43.15, for a total transaction of $32,362.50. Following the transaction, the insider now owns 18,237 shares in the company, valued at $786,926.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

The Advisory Board Co. (NASDAQ:ABCO) opened at 43.49 on Tuesday. The firm’s market cap is $1.75 billion. The Advisory Board Co. has a 52-week low of $18.87 and a 52-week high of $54.84. The firm’s 50-day moving average is $43.20 and its 200-day moving average is $37.49.

The Advisory Board (NASDAQ:ABCO) last issued its earnings results on Wednesday, July 27th. The company reported $0.47 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.34 by $0.13. The Advisory Board had a negative net margin of 10.21% and a positive return on equity of 11.59%. The firm earned $198.40 million during the quarter, compared to the consensus estimate of $196.49 million. During the same quarter in the prior year, the firm earned $0.40 earnings per share. The business’s quarterly revenue was up 7.4% on a year-over-year basis. Analysts forecast that The Advisory Board Co. will post $1.86 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for The Advisory Board (NASDAQ:ABCO)

A number of large investors have recently modified their holdings of ABCO. Vanguard Group Inc. increased its stake in shares of The Advisory Board by 1.3% in the second quarter. Vanguard Group Inc. now owns 2,968,858 shares of the company’s stock valued at $105,068,000 after buying an additional 38,458 shares during the last quarter. TimesSquare Capital Management LLC increased its stake in shares of The Advisory Board by 5.6% in the second quarter. TimesSquare Capital Management LLC now owns 2,633,187 shares of the company’s stock valued at $93,188,000 after buying an additional 140,465 shares during the last quarter. TPG Group Holdings SBS Advisors Inc. increased its stake in shares of The Advisory Board by 298.4% in the second quarter. TPG Group Holdings SBS Advisors Inc. now owns 2,144,589 shares of the company’s stock valued at $75,897,000 after buying an additional 1,606,256 shares during the last quarter. Janus Capital Management LLC increased its stake in shares of The Advisory Board by 146.3% in the second quarter. Janus Capital Management LLC now owns 1,744,564 shares of the company’s stock valued at $61,739,000 after buying an additional 1,036,216 shares during the last quarter. Finally, Royal Bank of Canada increased its stake in shares of The Advisory Board by 6.0% in the first quarter. Royal Bank of Canada now owns 1,252,911 shares of the company’s stock valued at $40,406,000 after buying an additional 70,769 shares during the last quarter.

ABCO has been the topic of several research analyst reports. Barclays PLC lifted their price objective on shares of The Advisory Board from $41.00 to $44.00 and gave the stock an “overweight” rating in a research report on Thursday, July 28th. FBR & Co lifted their price objective on shares of The Advisory Board from $35.00 to $37.00 and gave the stock a “mkt perform” rating in a research report on Thursday, July 28th. Oppenheimer Holdings Inc. reiterated an “outperform” rating and set a $49.00 price objective (up from $45.00) on shares of The Advisory Board in a research report on Wednesday, September 28th. Credit Suisse Group AG initiated coverage on shares of The Advisory Board in a research report on Monday, June 20th. They set an “outperform” rating and a $40.00 price objective on the stock. Finally, William Blair reiterated an “outperform” rating on shares of The Advisory Board in a research report on Tuesday, September 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The Advisory Board currently has a consensus rating of “Buy” and an average target price of $44.07.

About The Advisory Board

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Stock Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related stocks with our FREE daily email newsletter.